• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 06/07/2023
Event Type  malfunction  
Event Description
It was reported by customer that a patient with implanted port receiving continuous iv fluids.Rn entered room to do hourly iv check and found patient sitting in bed with a small break in iv tubing near cap.Found patient with blood on legs and around tubing with blood backing up into iv tubing.Iv tubing clamped closest to port insertion site, rn wiped tubing with chlorohexadine wipes, deaccessed port, cleaned skin with chlorohexidine bath, sterile access to reaccess port, new iv tubing and fluids hung.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The manufacturer has received the sample and is pending evaluation.Results are expected soon.
 
Event Description
It was reported by customer that a patient with implanted port receiving continuous iv fluids.Rn entered room to do hourly iv check and found patient sitting in bed with a small break in iv tubing near cap.Found patient with blood on legs and around tubing with blood backing up into iv tubing.Iv tubing clamped closest to port insertion site, rn wiped tubing with chlorohexadine wipes, deaccessed port, cleaned skin with chlorohexidine bath, sterile access to reaccess port, new iv tubing and fluids hung.Additional information received 01 august 2023: i was the rn who entered the patient¿s room doing my hourly iv/patient safety checks and saw the patient sitting up in his crib with what appeared to be (and was) blood over his legs/chest/crib sheet.His blood was backing up from his implanted port down the tubing and leaking from the port huber needle access tubing.The patient was wearing a onsie with the tubing underneath it but he had unsnapped the bottom of his onsie and the iv tubing was visible with blood coming out of it.It was very clear where the leak was.I cannot remember which iv fluids were infusing at the time but i believe it was post chemotherapy hydration fluids.The impact could have been a patient clabsi infection with an immunocompromised toddler which could be life threatening.It did cause a delay in care as the patient had to be cleaned (with chg wipes), the port had to be deaccessed, then reaccessed with a new huber needle and all new iv tubing and fluids.To the best of my knowledge the patient did not actually acquire a clabsi.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of a split extension tubing was confirmed and the cause is currently under investigation.The product returned for evaluation was one 20 ga powerloc max infusion set.The returned product sample was evaluated and the following observations were made: a tear in the extension tube was seen at the interface of the proximal luer adapter the fracture surfaces of the damage contained striation-like patterns which were indicative of flexural fatigue based failures, which may have been a contributing factor to the extension tubing damage.Repetitive mechanical stresses such as twisting and kinking may have contributed to the observed event; however, it appeared that additional unidentified factors also contributed.The device is a supplied component and the supplier has been notified of this event.
 
Event Description
It was reported by customer that a patient with implanted port receiving continuous iv fluids.Rn entered room to do hourly iv check and found patient sitting in bed with a small break in iv tubing near cap.Found patient with blood on legs and around tubing with blood backing up into iv tubing.Iv tubing clamped closest to port insertion site, rn wiped tubing with chlorohexidine wipes, deaccessed port, cleaned skin with chlorohexidine bath, sterile access to reaccess port, new iv tubing and fluids hung.Additional information received 01 august 2023: i was the rn who entered the patient¿s room doing my hourly iv/patient safety checks and saw the patient sitting up in his crib with what appeared to be (and was) blood over his legs/chest/crib sheet.His blood was backing up from his implanted port down the tubing and leaking from the port huber needle access tubing.The patient was wearing a onsie with the tubing underneath it but he had unsnapped the bottom of his onsie and the iv tubing was visible with blood coming out of it.It was very clear where the leak was.I cannot remember which iv fluids were infusing at the time but i believe it was post chemotherapy hydration fluids.The impact could have been a patient clabsi infection with an immunocompromised toddler which could be life threatening.It did cause a delay in care as the patient had to be cleaned (with chg wipes), the port had to be deaccessed, then reaccessed with a new huber needle and all new iv tubing and fluids.To the best of my knowledge the patient did not actually acquire a clabsi.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 0.75IN
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key17276082
MDR Text Key318559208
Report Number3006260740-2023-02806
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153440
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number0142075
Device Lot NumberASGZFC016
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/28/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/10/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age1 YR
Patient SexMale
-
-